| Old Articles: <Older 4861-4870 Newer> |
|---|
 |
Information Today
May 27, 2008 |
Google Health Now Available in Public Beta Users are offered a safe and secure way to collect, store, and manage their medical records and health information online.   |
The Motley Fool
May 27, 2008
Brian Orelli |
Livin' la Vivus Loca Irrational Exuberance for Vivus' Lead Drug Candidate? |
The Motley Fool
May 23, 2008
Brian Lawler |
Vertex's Lead Cut Down Schering-Plough is moving forward with its antiviral hepatitis C drug even faster than expected, much to Vertex's dismay. |
The Motley Fool
May 23, 2008
Brian Orelli |
Progenics' Mixed Trial Data Progenics Pharmaceuticals and marketing partner Wyeth release both positive and negative clinical trial data. |
The Motley Fool
May 22, 2008
Brian Orelli |
Merck Can't Achieve Anything The pharmaceutical cancels a troubled clinical trial. |
The Motley Fool
May 22, 2008
Brian Orelli |
Wyeth's Never-Ending Generic Woes Novartis jumps on the generic Protonix bandwagon. |
The Motley Fool
May 22, 2008
Brian Lawler |
All Is Not Lost for AstraZeneca's Iressa AstraZeneca's Iressa gets a little pep back. |
The Motley Fool
May 22, 2008
Brian Lawler |
Enzon Shareholders Steal the Show A shareholder tussle overshadows clinical trial data. |
The Motley Fool
May 21, 2008
Brian Orelli |
Dr. Reddy Needs an Amnesia Pill The pharmaceutical's year-over-year comparison headache is finally over. |
The Motley Fool
May 21, 2008
Brian Orelli |
Medtronic's Endeavors Look Good The medical device maker's new drug-eluting stent helps push up revenue. |
| <Older 4861-4870 Newer> Return to current articles. |
